Pharmacoeconomic review report. Ozenoxacin 1% cream (Ozanex), (Ferrer internacional, S.A.) : indication : the topical treatment of impetigo in patients aged two months and older.

Pharmacoeconomic review report. indication : the topical treatment of impetigo in patients aged two months and older. Ozenoxacin 1% cream (Ozanex), (Ferrer internacional, S.A.) :

Show other versions (2)

Ozenoxacin 1% cream is a topical non-fluorinated quinolone antibiotic indicated for the treatment of impetigo in patients aged two months or older. The recommended use for ozenoxacin is the application of a thin layer of cream to affected areas twice daily for five days. It is available in 10 g tube...

Full description

Saved in:
Bibliographic Details
Online Access: Full text
Format: Electronic eBook
Language:English
Published: Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2018
Series:Common drug review clinical review report.
Subjects:
Impetigo > drug therapy.
Infant.
Child.
Quinolones > therapeutic use.
Quinolones > economics.
Cost-Benefit Analysis.
Children.
Family members.
Canada.
Tables.

Internet

Full text

Similar Items